Compare ResMed Inc. (RMD) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Teucrium Soybean Fund — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Teucrium Soybean Fund trades at $25.86. The key difference: ResMed Inc. pays a 1.21% dividend while Teucrium Soybean Fund pays none, and Teucrium Soybean Fund is trading nearer its 52-week high, ResMed Inc. nearer its low. Which is the better fit depends on your goals.
| RMD | SOYB | |
|---|---|---|
Market Cap | $28.81B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $293.73 | $25.88 |
52-Week Low | $182.82 | $21.07 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOYB is trading at $25.88, up 1.53% today with strong technical momentum as moving averages signal bullish sentiment. The stock shows mixed oscillator readings with RSI suggesting potential overbought conditions. Recent agricultural sector news highlights potential tailwinds from China's $17 billion crop purchase commitment through 2028, which could benefit agricultural companies.
The stock presents bullish technical positioning but requires fundamental validation through upcoming earnings reports. Key risks include commodity price volatility and execution challenges. Upside potential exists if the company can capitalize on agricultural export opportunities, though investors should await financial metric updates for proper valuation assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
